OmniAb Investor Presentation Deck
Matt Foehr
Chief Executive Officer
Board Member Viking Therapeutics
Former Exec at Ligand Pharmaceuticals,
GlaxoSmithKline,
Stiefel Labs, Connetics Corp.
Carolyn Bertozzi, PhD
Professor of Humanities & Sciences
Stanford University
Investigator HHMRI
2022 Nobel Laureate
Board Member Alnylam
Former Board Member Eli Lilly,
Founder of multiple companies
S&T Chair, Nom/Gov
Kurt Gustafson
Chief Financial Officer
Board Member Xencor, Inc
Former CFO/Exec at
Spectrum Pharmaceuticals,
Halozyme Therapeutics, Amgen
Sarah Boyce
CEO, Avidity
Former Akcea Therapeutics,
lonis Pharmaceuticals, Forest Labs
HC&C Chair
Charles Berkman
Chief Legal Officer
Former General Counsel
Bill Harriman, PhD
SVP, Antibody Discovery
Co-Founder/CSO, Crystal Bioscience
Trellis, Roche, Abgenix
UCSF-Immunology, Haas MBA
Board of Directors
at Ligand Pharmaceuticals,
Attorney at Baker & McKenzie,
Lyon & Lyon
Management
Jennifer Cochran, PhD
Professor of Bioengineering
Stanford University
Founder of multiple companies,
including xCella Biosciences
Nom/Gov Chair, AC, S&T
Christel Iffland, PhD
SVP, Antibody Technologies
Former Associate Director at Merck
KGaA / EMD Serono
Co-inventor of Avelumab
Dana Farber,
Albert Einstein College
John Higgins
OmniAb, Inc. Board Chair
CEO and Board Member,
Ligand armaceuticals
Former CFO, Connetics Corp.
Board Member Bio-Techne
HC&C
Sunil Patel
Public & Private Biotech Executive
Former Abgenix, Gilead,
BiPar and OncoMed
AC Chair, HC&C, S&T
Marie-Cecile
Van De Lavoir, PhD, DVM
SVP, Technical Operations & Genetics
Co-Founder/COO, Crystal Bioscience
Origen Therapeutics, Inventor Germ
Cell Technology Fulbright Scholar,
UCSF, Utrecht, Guelph, Cornell
Josh Tamaroff
Partner, Avista Capital Partners
Barclays Capital
Lehman Brothers
AC, Nom/Gov
35
Doug Krafte, PhD
SVP, Ion Channels
Former Exec at Icagen Inc., Pfizer Pain
& Sensory Disorders, Boehringer
Ingelheim, Aurora Biosciences
Univ. Rochester, Vanderbilt
Matt Foehr
Chief Executive Officer
Board Member Viking Therapeutics
Former Exec at Ligand Pharmaceuticals,
GlaxoSmithKline,
Stiefel Labs, Connetics Corp.
OmniAbView entire presentation